Suven Pharmaceuticals Ltd
NSE:SUVENPHAR
Suven Pharmaceuticals Ltd
NSE:SUVENPHAR
Price:
635.55 INR
0.81%
Market Closed
Updated:
Jun 6, 2024
Suven Pharmaceuticals Ltd
Total Other Income
|
Suven Pharmaceuticals Ltd
Total Other Income Peer Comparison
Comparables:
DRREDDY
CIPLA
SUNPHARMA
ZYDUSLIFE
T
TORNTPHARM
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Suven Pharmaceuticals Ltd
NSE:SUVENPHAR
|
Total Other Income
₹34m
|
CAGR 3-Years
69%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Total Other Income
₹7.4B
|
CAGR 3-Years
160%
|
CAGR 5-Years
129%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Total Other Income
₹7.5B
|
CAGR 3-Years
124%
|
CAGR 5-Years
45%
|
CAGR 10-Years
11%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Total Other Income
₹11.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
1%
|
CAGR 10-Years
9%
|
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Total Other Income
₹2.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
152%
|
CAGR 10-Years
19%
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Total Other Income
₹361.4m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
0%
|
See Also
What is Suven Pharmaceuticals Ltd's Total Other Income?
Total Other Income
34m
INR
34m
INR
Based on the financial report for Mar 31, 2023, Suven Pharmaceuticals Ltd's Total Other Income amounts to 34m INR.
What is Suven Pharmaceuticals Ltd's Total Other Income growth rate?
Total Other Income CAGR 3Y
69%
69%
Over the last year, the Total Other Income growth was -96%. The average annual Total Other Income growth rates for Suven Pharmaceuticals Ltd have been 69% over the past three years .
You don't have any saved screeners yet
